Cargando…

Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients

BACKGROUND: Financial toxicity is a consequence of subjective financial distress experienced by cancer patients as a result of treatment expenditures. Financial toxicity has been associated with poor quality of life, early mortality, and non-adherence. It is evident from the literature that the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dar, Mukhtar Ahmad, Chauhan, Richa, Murti, Krishna, Trivedi, Vinita, Dhingra, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847677/
https://www.ncbi.nlm.nih.gov/pubmed/35186720
http://dx.doi.org/10.3389/fonc.2021.819313
_version_ 1784652095423512576
author Dar, Mukhtar Ahmad
Chauhan, Richa
Murti, Krishna
Trivedi, Vinita
Dhingra, Sameer
author_facet Dar, Mukhtar Ahmad
Chauhan, Richa
Murti, Krishna
Trivedi, Vinita
Dhingra, Sameer
author_sort Dar, Mukhtar Ahmad
collection PubMed
description BACKGROUND: Financial toxicity is a consequence of subjective financial distress experienced by cancer patients as a result of treatment expenditures. Financial toxicity has been associated with poor quality of life, early mortality, and non-adherence. It is evident from the literature that the currently available instruments for the assessment of financial toxicity do not measure coping and support seeking domains. The aim of this study was to develop an instrument for the assessment of financial toxicity among radiation oncology patients that captures and integrates all the relevant domains of subjective financial distress. MATERIALS AND METHODS: The study was conducted among Head & Neck cancer (HNC) patients (age ≥18 years) who have completed the radiotherapy either as stand-alone or part of a multimodal treatment. Literature review, expert opinion, and patient interviews were used for scale item generation. The validity and underlying factor structure were evaluated by Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA). The reliability and internal consistency of the final scale was assessed using Cronbach’s alpha coefficient. RESULTS: A total of 17 items were identified for scale development. The preliminary 17-item instrument was administered to 142 HNC patients. Among 142 participants, 85.9% were male and 98.6% were from rural areas. EFA was performed on 17 items and three items were removed (factor loadings <0.5). The remaining 14 items loaded onto three factors (eigenvalue >1) explaining 62.0% of the total variance. The Chi-square goodness of fit test in CFA and the values of other model fit indices, namely, RMSEA = 0.045, SRMR = 0.014, GFI = 0.92, CFI = 0.98, and TLI=0.97 indicate a good model fit suggesting the three-factor model adequately fits the data. The Cronbach’s α for the final 14-item scale was 0.87 indicating excellent reliability and the Cronbach’s α coefficient of all the individual 14 items was ≥0.85 (range 0.85–0.88). CONCLUSION: The SFDQ showed excellent validity and reliability. SFDQ captures and integrates all the relevant domains of financial toxicity. However, the provisional SFDQ instrument warrants further larger sample studies for validation and psychometric evaluation in different primary cancer subsites and treatment modalities from multiple cancer centers to improve the generalizability of this instrument.
format Online
Article
Text
id pubmed-8847677
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88476772022-02-17 Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients Dar, Mukhtar Ahmad Chauhan, Richa Murti, Krishna Trivedi, Vinita Dhingra, Sameer Front Oncol Oncology BACKGROUND: Financial toxicity is a consequence of subjective financial distress experienced by cancer patients as a result of treatment expenditures. Financial toxicity has been associated with poor quality of life, early mortality, and non-adherence. It is evident from the literature that the currently available instruments for the assessment of financial toxicity do not measure coping and support seeking domains. The aim of this study was to develop an instrument for the assessment of financial toxicity among radiation oncology patients that captures and integrates all the relevant domains of subjective financial distress. MATERIALS AND METHODS: The study was conducted among Head & Neck cancer (HNC) patients (age ≥18 years) who have completed the radiotherapy either as stand-alone or part of a multimodal treatment. Literature review, expert opinion, and patient interviews were used for scale item generation. The validity and underlying factor structure were evaluated by Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA). The reliability and internal consistency of the final scale was assessed using Cronbach’s alpha coefficient. RESULTS: A total of 17 items were identified for scale development. The preliminary 17-item instrument was administered to 142 HNC patients. Among 142 participants, 85.9% were male and 98.6% were from rural areas. EFA was performed on 17 items and three items were removed (factor loadings <0.5). The remaining 14 items loaded onto three factors (eigenvalue >1) explaining 62.0% of the total variance. The Chi-square goodness of fit test in CFA and the values of other model fit indices, namely, RMSEA = 0.045, SRMR = 0.014, GFI = 0.92, CFI = 0.98, and TLI=0.97 indicate a good model fit suggesting the three-factor model adequately fits the data. The Cronbach’s α for the final 14-item scale was 0.87 indicating excellent reliability and the Cronbach’s α coefficient of all the individual 14 items was ≥0.85 (range 0.85–0.88). CONCLUSION: The SFDQ showed excellent validity and reliability. SFDQ captures and integrates all the relevant domains of financial toxicity. However, the provisional SFDQ instrument warrants further larger sample studies for validation and psychometric evaluation in different primary cancer subsites and treatment modalities from multiple cancer centers to improve the generalizability of this instrument. Frontiers Media S.A. 2022-02-02 /pmc/articles/PMC8847677/ /pubmed/35186720 http://dx.doi.org/10.3389/fonc.2021.819313 Text en Copyright © 2022 Dar, Chauhan, Murti, Trivedi and Dhingra https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Dar, Mukhtar Ahmad
Chauhan, Richa
Murti, Krishna
Trivedi, Vinita
Dhingra, Sameer
Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients
title Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients
title_full Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients
title_fullStr Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients
title_full_unstemmed Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients
title_short Development and Validation of Subjective Financial Distress Questionnaire (SFDQ): A Patient Reported Outcome Measure for Assessment of Financial Toxicity Among Radiation Oncology Patients
title_sort development and validation of subjective financial distress questionnaire (sfdq): a patient reported outcome measure for assessment of financial toxicity among radiation oncology patients
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847677/
https://www.ncbi.nlm.nih.gov/pubmed/35186720
http://dx.doi.org/10.3389/fonc.2021.819313
work_keys_str_mv AT darmukhtarahmad developmentandvalidationofsubjectivefinancialdistressquestionnairesfdqapatientreportedoutcomemeasureforassessmentoffinancialtoxicityamongradiationoncologypatients
AT chauhanricha developmentandvalidationofsubjectivefinancialdistressquestionnairesfdqapatientreportedoutcomemeasureforassessmentoffinancialtoxicityamongradiationoncologypatients
AT murtikrishna developmentandvalidationofsubjectivefinancialdistressquestionnairesfdqapatientreportedoutcomemeasureforassessmentoffinancialtoxicityamongradiationoncologypatients
AT trivedivinita developmentandvalidationofsubjectivefinancialdistressquestionnairesfdqapatientreportedoutcomemeasureforassessmentoffinancialtoxicityamongradiationoncologypatients
AT dhingrasameer developmentandvalidationofsubjectivefinancialdistressquestionnairesfdqapatientreportedoutcomemeasureforassessmentoffinancialtoxicityamongradiationoncologypatients